Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low-risk clinical trials
- PMID: 34613653
- DOI: 10.1002/pbc.29399
Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low-risk clinical trials
Keywords: Biliary tract neoplasms; biliary tract; embryonal rhabdomyosarcoma; neoplasm staging; rhabdomyosarcoma.
Comment in
-
Comment on: Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low-risk clinical trials.Pediatr Blood Cancer. 2022 Jul;69(7):e29554. doi: 10.1002/pbc.29554. Epub 2021 Dec 28. Pediatr Blood Cancer. 2022. PMID: 34962698 No abstract available.
References
REFERENCES
-
- Lawrence W, Gehan EA, Hays DM, Beltangady M, Maurer HM. Prognostic significant of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). J Clin Oncol. 1987;5:46-54.
-
- Spunt SL, Lobe TE, Pappo AS, et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 2000;35:309-316.
-
- Aye JM, Xue W, Palmer JD, et al. Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: a report from the children's oncology group. Pediatr Blood Cancer. 2021;68:e28914.
-
- Maurer HM, Crist W, Lawrence W, et al. The Intergroup Rhabdomyosarcoma Study - I. A final report. Cancer. 1988;61:209-220.
-
- Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study - II. Cancer. 1993;71:1904-1922.
MeSH terms
LinkOut - more resources
Full Text Sources
